Listed

ImmunityBio, Inc.: Form 10-Q for the period ended Sep 30, 2017

Filed with the SEC on Nov 7, 2017 and accepted by EDGAR at Nov 7, 2017, 16:04 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2017-09-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2017-07-01 to 2017-09-30$8.0kus-gaap:Revenues
Revenue9 months2017-01-01 to 2017-09-30$33.0kus-gaap:Revenues
Research and development3 months2017-07-01 to 2017-09-30$11.1mus-gaap:ResearchAndDevelopmentExpense
Research and development9 months2017-01-01 to 2017-09-30$30.0mus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative3 months2017-07-01 to 2017-09-30$13.4mus-gaap:SellingGeneralAndAdministrativeExpense
Selling, general and administrative9 months2017-01-01 to 2017-09-30$43.7mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2017-07-01 to 2017-09-30−$24.4mus-gaap:OperatingIncomeLoss
Operating income9 months2017-01-01 to 2017-09-30−$73.7mus-gaap:OperatingIncomeLoss
Interest expense3 months2017-07-01 to 2017-09-30$393.0kus-gaap:InterestExpense
Interest expense9 months2017-01-01 to 2017-09-30$584.0kus-gaap:InterestExpense
Income tax3 months2017-07-01 to 2017-09-30−$99.0kus-gaap:IncomeTaxExpenseBenefit
Income tax9 months2017-01-01 to 2017-09-30−$321.0kus-gaap:IncomeTaxExpenseBenefit
Net income3 months2017-07-01 to 2017-09-30−$24.0mus-gaap:NetIncomeLoss
Net income9 months2017-01-01 to 2017-09-30−$71.9mus-gaap:NetIncomeLoss
Diluted EPS3 months2017-07-01 to 2017-09-30−$0.30us-gaap:EarningsPerShareBasicAndDiluted
Diluted EPS9 months2017-01-01 to 2017-09-30−$0.89us-gaap:EarningsPerShareBasicAndDiluted
Capital expenditure9 months2017-01-01 to 2017-09-30$23.4mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Share repurchases9 months2017-01-01 to 2017-09-30$12.5mus-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2017-09-30$20.9mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2017-09-30$156.9mus-gaap:AssetsCurrent
Total assetsAt period end2017-09-30$277.7mus-gaap:Assets
Current liabilitiesAt period end2017-09-30$28.7mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2017-09-30$40.0mus-gaap:Liabilities
Shareholders' equityAt period end2017-09-30$237.7mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001564590-17-022217. Last ingested by Listed: Nov 9, 2026, 17:45 ET. Listed shows no prices and gives no investment advice.